Astera Labs (NASDAQ:ALAB) Hits New 52-Week High – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB) hit a new 52-week high during trading on Thursday . The stock traded as high as $398.37 and last traded at $405.2750, with a volume of 825886 shares. The stock had previously closed at $374.68.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on ALAB shares. Royal Bank Of Canada increased their price target on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Citigroup cut shares of Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Needham & Company LLC increased their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Roth Mkm restated a “buy” rating and set a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

Astera Labs Stock Performance

The stock has a market capitalization of $72.00 billion, a price-to-earnings ratio of 284.30, a price-to-earnings-growth ratio of 4.79 and a beta of 3.95. The business has a fifty day simple moving average of $252.64 and a 200 day simple moving average of $183.89.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company’s revenue was up 93.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 796 shares of Astera Labs stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total transaction of $231,659.88. Following the completion of the sale, the general counsel owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 2,161,256 shares of company stock worth $459,844,296. 10.40% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Astera Labs

A number of large investors have recently added to or reduced their stakes in the stock. Eurizon Capital SGR S.p.A. bought a new position in Astera Labs in the 4th quarter valued at about $18,708,000. Nordea Investment Management AB bought a new stake in shares of Astera Labs during the 4th quarter worth approximately $2,028,000. Geneva Partners LLC bought a new stake in shares of Astera Labs during the 3rd quarter worth approximately $1,876,000. Swedbank AB boosted its position in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after acquiring an additional 33,940 shares in the last quarter. Finally, Numerai GP LLC boosted its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares in the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.